Qiagen, WuXi AppTec Forge Biomarker Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Shanghai-based biotech firm WuXi AppTec said today that it will partner with Qiagen to develop an integrated biomarker service, as well as new biomarkers and assays.

Under the agreement, Qiagen will provide tools, training, and consumables, while WuXi will contribute its Shanghai lab facilities and staff to conduct the biomarker services. The lab is scheduled to begin operating immediately.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.